Medicinal Products

Adempas

Name Adempas
Active Substance riociguat
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code C02KX05
Medicinal product marketed in the Croatia Da

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/adempas

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novoj kontraindikaciji lijeka Adempas (riocigvat) za bolesnike s plućnom hipertenzijom povezanom s idiopatskim intersticijskim pneumonijama (PH IIP) 04.07.2016 Bayer d.o.o. i Merck Sharp & Dohme d.o.o.
Back